Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innovations Group Plc LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 2.80 2.70 2.90 2.80 2.80 2.80 13,783 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 6.3 -3.3 -0.4 - 26

Surgical Innovations Group PLC Launch of the Green Surgery Challenge

09/02/2021 7:00am

RNS Non-Regulatory


TIDMSUN

Surgical Innovations Group PLC

09 February 2021

Surgical Innovations Group plc

("Surgical Innovations", "SI" or the "Company")

Launch of the Green Surgery Challenge

Event sponsor to promote the use of sustainable products in surgery

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces that Elemental Healthcare Limited, a wholly owned SI subsidiary, was a key sponsor at the launch of the Green Surgery Challenge 2021*, which took place last week.

This competition , initiated by Elemental Healthcare and developed by the Centre for Sustainable Healthcare ("CSH"), allows UK operating theatres to present innovative ideas to reduce their Carbon Footprint. The national competition has been organised by the CSH, Royal College of Surgeons England, Royal College of Surgeons of Scotland and NIHR Surgical Med Tech Co-op and is endorsed by a number of significant charities and official bodies.

The Green Surgery Challenge 2021 is an opportunity for the UK's surgical community to recognise the value of sustainable healthcare for surgical conditions, share and promote ways of practicing that are less harmful to the environment and the planet and build social sustainability, transforming surgery for the future. The launch event attracted over 400 delegates.

The recording can be accessed here: https://youtu.be/Nb2EimC2-0c

As announced in November 2020, SI has an ongoing collaboration with the CSH, enabling the Company to validate the environmental messaging for SI's products and demonstrate the quantifiable benefits in cost and environmental savings from a 'greener' operating room, with particular focus on reducing plastic waste in surgery in the UK and globally.

Adam Power, SI Group Development Director, commented: "We are pleased to be part of the Green Surgery Challenge launch, bringing sustainability to the forefront of hospital agendas. We are one of the only significant players in the space with our Resposable (TM) product portfolio and are passionate to lead and support innovative ideas to reduce public sector waste and emissions, much of which comes from NHS surgical procedures."

*More information on the Green Surgery Challenge 2021 can be found here - Green Surgery Challenge | Centre for Sustainable Healthcare

For further information please contact:

 
 Surgical Innovations Group plc                              www sigroupplc com 
 David Marsh, CEO                                            Tel: 0113 230 7597 
 Charmaine Day, Co Sec & GFC 
 
 N+1 Singer (Nominated Adviser &                             Tel: 020 7496 3000 
  Broker) 
   Aubrey Powell / Rachel Hayes/ Iqra 
    Amin 
 
 Walbrook PR (Financial PR & Investor   Tel: 020 7933 8780 or si@walbrookpr.com 
  Relations) 
 Paul McManus / Lianne Cawthorne             Mob: 07980 541 893 / 07584 391 303 
 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.

We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part re-usable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.

Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.

In addition, we design and develop medical devices for carefully selected OEM partners, and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.

We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment.

The Group currently employs approximately 100 people across two sites in the UK. Product design, engineering and manufacturing are carried out at the SI site in Yorkshire. Commercial activities including marketing, UK distribution and international sales and marketing are based at Elemental Healthcare in Berkshire.

Further information

Further details of the Group's businesses are available on the following websites:

www.sigroupplc.com

www.surginno.com

www.elementalhealthcare.co.uk

To receive regular updates by email, please contact si@walbrookpr.com .

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAMZGGZMRNGMZZ

(END) Dow Jones Newswires

February 09, 2021 02:00 ET (07:00 GMT)

1 Year Surgical Innovations Chart

1 Year Surgical Innovations Chart

1 Month Surgical Innovations Chart

1 Month Surgical Innovations Chart
ADVFN Advertorial
Your Recent History
LSE
SUN
Surgical I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210726 14:22:49